Literature DB >> 6556451

Vanadate and brain adenylate cyclase. Effect of spreading depression.

J Krivánek.   

Abstract

The effect of vanadate on the adenylate cyclase activity of rat cerebral cortex homogenates is described. In the absence of ethyleneglycol-bis-(beta-aminoethyl ether) N,N'-tetraacetic acid (EGTA), 10(-6)M vanadate inhibited enzyme activity by 23%, while 10 (-4) M and 10(-3) M stimulated the enzyme by 14 and 90%, respectively. In the presence of 0.2 mM EGTA, 10 (-6) M to 10(-3) M vanadate had only stimulating effects (18-450%). Additive effects of vanadate and noradrenaline on adenylate cyclase activity suggest different sites of action of these agents. Interaction of vanadate with both fluoride and guanyl-5'-yl imidodiphosphate had an apparently competitive character. Adenylate cyclase maximally stimulated by fluoride (10 mM) was inhibited by vanadate. This inhibitory effect was more pronounced in the absence of EGTA. Adenylate cyclase in the homogenates from the rat cerebral cortex in vivo invaded by spreading depression was slightly increased (up to 38%). This effect was abolished by low (10 (-7) M) vanadate. The results suggest that brain adenylate cyclase is stimulated by vanadate via the guanine nucleotide regulatory protein. The mechanism of vanadate's action, its modulation by calcium ions and the possible physiological role of these effects are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6556451     DOI: 10.1016/0306-4522(83)90151-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  2 in total

1.  Effect of vanadate on brain protein phosphorylation.

Authors:  J Krivánek
Journal:  Neurochem Res       Date:  1984-11       Impact factor: 3.996

Review 2.  Ligands of the Neuropeptide Y Y2 Receptors as a Potential Multitarget Therapeutic Approach for the Protection of the Neurovascular Unit Against Acute Ischemia/Reperfusion: View from the Perspective of the Laboratory Bench.

Authors:  Łukasz Przykaza; Ewa Kozniewska
Journal:  Transl Stroke Res       Date:  2021-07-22       Impact factor: 6.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.